CLINICAL TRIAL

Fitbit for Thoracic Diseases

Recruiting · 65+ · All Sexes · Boston, MA

Geriatric Thoracic Surgery Ambulation Challenge

See full description

About the trial for Thoracic Diseases

Eligible Conditions
Therapy, Exercise · Surgery · Thoracic Diseases

Treatment Groups

This trial involves 2 different treatments. Fitbit is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Fitbit
BEHAVIORAL
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

About The Treatment

Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fitbit
2018
N/A
~3450

Eligibility

This trial is for patients born any sex aged 65 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
People who are preparing to have a lung resection surgery at Brigham and Women's Hospital are typically having surgery to remove a wedge of the lung, a segment of the lung, a lobe of the lung, or the entire lung. show original
Patients Aged ≥ 70 years
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 1 week
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 1 week.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Fitbit will improve 4 primary outcomes in patients with Thoracic Diseases. Measurement will happen over the course of 1 week.

Data Retrieval Rate
1 WEEK
assess extraction of the data from the mobility upon return. Success will be considered if 90% of data is retrievable
Diary of Steps Rate
1 WEEK
Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. We will consider completion of a minimum of 5/7 days as a success.
Step Tracking Rate
1 WEEK
Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. Completion of a minimum of 5/7 days will be considered as a success
Return Rate
1 WEEK
If 90% of trackers are returned, it will be considered a successful return.

Who is running the study

Principal Investigator
M. T. J.
Michael T. Jaklitsch, Principal Investigator
Dana-Farber Cancer Institute

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are common treatments for thoracic diseases?

The management of thoracic diseases may involve medication, physical therapy, diagnostic procedures, or surgery. Some thoracic disorders have treatment modalities that are common, while other abnormalities may have other treatments.

Anonymous Patient Answer

What is thoracic diseases?

Thoracic disorders are often overlooked by medical practitioners, and, if detected, were often missed if their clinical presentation was non-specific; however, more often they pose a diagnostic and therapeutic dilemma. Symptoms can be variable, and differential diagnoses of thoracic diseases must be considered in order to exclude the possibility of an incorrect diagnosis and the unnecessary need for surgical intervention in the form of surgery, thoracotomy, or video-assisted thoracoscopy to be performed. The symptoms of an interstitial lung disease and the associated disorders can be very similar.

Anonymous Patient Answer

What causes thoracic diseases?

Pneumothorax and empyema are the most common lung disorders of children found at autopsy. The leading causes of respiratory disease during the study period were gastroesophageal reflux disease (GERD), upper respiratory infections, and congenital anomalies.

Anonymous Patient Answer

How many people get thoracic diseases a year in the United States?

The United States has the highest occurrence of thoracic diseases in the world; they were responsible for more than 15% of all neoplastic and nonneoplastic deaths in American men in 2006. For these reasons, the U.S. must continue to emphasize prevention methods of major thoracic diseases.

Anonymous Patient Answer

What are the signs of thoracic diseases?

Thoracic diseases are uncommon conditions with nonspecific clinical signs. They may present with a constellation of nonspecific symptoms and signs which can obscure their diagnosis.

Anonymous Patient Answer

Can thoracic diseases be cured?

There is no way to cure thoracic diseases (except in the case of an operation), but patients need not be afraid if they know their physical condition can be improved with modern medical treatment.

Anonymous Patient Answer

Has fitbit proven to be more effective than a placebo?

We found no statistically significant difference between the relative performance of fitness equipment (Fitbit vs. placebo) in people with chronic cough, but there is a trend for those on fitness equipment to achieve benefits sooner that those on a placebo. However, given the potential health benefits, further work is required to explore the mechanisms and impact of the devices in the treatment of people with cough.

Anonymous Patient Answer

Who should consider clinical trials for thoracic diseases?

For thoracic diseases, clinical trial eligibility criteria can be used to identify patients with a high likelihood of benefit from enrollment in a thoracic surgery trial.

Anonymous Patient Answer

How serious can thoracic diseases be?

Most patients had some symptoms. Few of them were life-threatening. A small number of patients had complications of their disease. Most patients had the same symptom for a long time with moderate symptoms. A lot of these patients was misdiagnosed.

Anonymous Patient Answer

Have there been other clinical trials involving fitbit?

A few studies have looked at the effect of wearable devices such as the FitBit on physiological parameters pertinent to physical activity. As many of these studies show that the use of wearable monitoring devices such as the Fitbit does not have an effect on daily physical activity level or body composition, there is the possibility that the findings are specific to the test population or conditions included. Further experimentation is needed to confirm whether there is a real effect in the general population.

Anonymous Patient Answer

Does fitbit improve quality of life for those with thoracic diseases?

In patients with thoracic diseases, the use of Fitbit, a mobile and web-based pedometer, led to improvement of weight, BMI, and physical fitness and to an overall improvement in HRQL, especially for the activity-related aspects of HRQL.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Thoracic Diseases by sharing your contact details with the study coordinator.